Authors: Chauret, N Yergey, JA Brideau, C Friesen, RW Mancini, J Riendeau, D Silva, J Styhler, A Trimble, LA Nicoll-Griffith, DA

Citation: N. Chauret et al., In vitro metabolism considerations, including activity testing of metabolites, in the discovery and selection of the COX-2 inhibitor etoricoxib (MK-0663), BIOORG MED, 11(8), 2001, pp. 1059-1062

Authors: Brideau, C Van Staden, C Styhler, A Rodger, IW Chan, CC

Citation: C. Brideau et al., The effects of phosphodiesterase type 4 inhibitors on tumour necrosis factor-alpha and leukotriene B-4 in a novel human whole blood assay, BR J PHARM, 126(4), 1999, pp. 979-988